van Haaften, Caroline <br/><br/>
Chemosensitivity of BRCA1-Mutated Ovarian Cancer Cells and Established Cytotoxic Agents.  [electronic resource] 

 -  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society  10 2017 
 - 1571-1578 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1525-1438 
<br/><br/><label>Standard No.: </label>10.1097/IGC.0000000000001052  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>BRCA1 Protein--genetics<br/>Cell Line, Tumor<br/>Cisplatin--administration & dosage<br/>Cystadenocarcinoma, Serous--drug therapy<br/>Drug Resistance, Neoplasm<br/>Drug Synergism<br/>Female<br/>Genes, BRCA1<br/>Germ-Line Mutation<br/>Humans<br/>Immunohistochemistry<br/>Lactones--administration & dosage<br/>Ovarian Neoplasms--drug therapy<br/>Phthalazines--administration & dosage<br/>Piperazines--administration & dosage<br/>Sesquiterpenes--administration & dosage